Jeffrey E. Lee

Jeffrey E. Lee

Auto-generated profile, based on publicly available information

Jeffrey E. Lee

Department of Laboratory Medicine and Pathobiology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2016 in Nature
Verified
Journal Article
Closed access
PDF file
HAHalil Aydin
Halil Aydin
ASAzmiri Sultana
Azmiri Sultana
SLSheng Li
Sheng Li
ATAnnoj Thavalingam
Annoj Thavalingam
JLJeffrey E. Lee
Jeffrey E. Lee

16 May 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JCJonathan D. Cook
Jonathan D. Cook
JLJeffrey E. Lee
Jeffrey E. Lee

30 August 2021 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
KSKaren K. Siu
Karen K. Siu
VSVitor Hugo Balasco Serrao
Vitor Hugo Balasco Serrao
AZAhmed Ziyyat
Ahmed Ziyyat
JLJeffrey E. Lee
Jeffrey E. Lee
Fertilization is defined as the union of two gametes. During fertilization, sperm and egg fuse to form a diploid zygote to initiate prenatal development. In mammals, fertilization involves multiple ordered steps, including the acrosome reaction, zona pellucida penetration, sperm–egg attachment, and membrane fusion. Given the success of in vitro fertilization, one would think that the mechanisms of fertilization are understood; however, the precise details for many of the steps in fertilization remain a mystery. Recent studies using genetic knockout mouse models and structural biology are providing valuable insight into the molecular basis of sperm–egg attachment and fusion. Here, we review the cell biology of fertilization, specifically summarizing data from recent structural and functional studies that provide insights into the interactions involved in human gamete attachment and fusion.

4 November 2013 in Nature Communications
Verified
Journal Article
Open access
PDF file
KSKaren K. Siu
Karen K. Siu
ASAzmiri Sultana
Azmiri Sultana
FAFarshad C. Azimi
Farshad C. Azimi
JLJeffrey E. Lee
Jeffrey E. Lee
The human APOBEC3 family of DNA cytosine deaminases serves as a front-line intrinsic immune response to inhibit the replication of diverse retroviruses. APOBEC3F and APOBEC3G are the most potent factors against HIV-1. As a countermeasure, HIV-1 viral infectivity factor (Vif) targets APOBEC3s for proteasomal degradation. Here we report the crystal structure of the Vif-binding domain in APOBEC3F and a novel assay to assess Vif-APOBEC3 binding. Our results point to an amphipathic surface that is conserved in APOBEC3s as critical for Vif susceptibility in APOBEC3F. Electrostatic interactions likely mediate Vif binding. Moreover, structure-guided mutagenesis reveals a straight ssDNA-binding groove distinct from the Vif-binding site, and an ‘aromatic switch’ is proposed to explain DNA substrate specificities across the APOBEC3 family. This study opens new lines of inquiry that will further our understanding of APOBEC3-mediated retroviral restriction and provides an accurate template for structure-guided development of inhibitors targeting the APOBEC3-Vif axis.

1 May 2014 in Structure
Verified
Journal Article
Closed access
HAHalil Aydin
Halil Aydin
MTMatthew W. Taylor
Matthew W. Taylor
JLJeffrey E. Lee
Jeffrey E. Lee

1 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
TGTeklab Gebregiworgis
Teklab Gebregiworgis
YKYoshihito Kano
Yoshihito Kano
JSJonathan St-Germain
Jonathan St-Germain
NRNikolina Radulovich
Nikolina Radulovich
MUMolly L. Udaskin
Molly L. Udaskin
MIMitsuhiko Ikura
Mitsuhiko Ikura
Cancer cells bearing distinct KRAS mutations exhibit variable sensitivity to SHP2 inhibitors (SHP2i). Here we show that cells harboring KRAS Q61H are uniquely resistant to SHP2i, and investigate the underlying mechanisms using biophysics, molecular dynamics, and cell-based approaches. Q61H mutation impairs intrinsic and GAP-mediated GTP hydrolysis, and impedes activation by SOS1, but does not alter tyrosyl phosphorylation. Wild-type and Q61H-mutant KRAS are both phosphorylated by Src on Tyr32 and Tyr64 and dephosphorylated by SHP2, however, SHP2i does not reduce ERK phosphorylation in KRAS Q61H cells. Phosphorylation of wild-type and Gly12-mutant KRAS, which are associated with sensitivity to SHP2i, confers resistance to regulation by GAP and GEF activities and impairs binding to RAF, whereas the near-complete GAP/GEF-resistance of KRAS Q61H remains unaltered, and high-affinity RAF interaction is retained. SHP2 can stimulate KRAS signaling by modulating GEF/GAP activities and dephosphorylating KRAS, processes that fail to regulate signaling of the Q61H mutant.